Bedel Financial Consulting, Inc. Ionis Pharmaceuticals Inc Transaction History

Bedel Financial Consulting, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$29.88 - $37.04 $1,135 - $1,407	-38 Closed	0 $0
Q2 2020 Jul 14, 2020	SELL	$46.85 - $61.05 $4,685 - $6,105	-100 Reduced 72.46%	38 $2,000
Q1 2020 May 06, 2020	BUY	$41.6 - $63.4 $4,160 - $6,340	100 Added 263.16%	138 $7,000
Q3 2019 Oct 09, 2019	BUY	$59.06 - $72.15 $2,244 - $2,741	38 New	38 $2,000

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.66B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.